FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sang-We Kim

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Seung Jin Lee; Dae Hyuk Moon; Seung Jun Oh; Jin Sook Ryu; Jin-Hee Ahn; Eun Jung Kim; Seog Young Kim; Haeng Jung Lee; Sang-We Kim
A pilot study for the early assessment of the effects of BMS-754807 plus gefitinib in an H292 tumor model by [(18)F]fluorothymidine-positron emission tomography.
Borae G Park; Chan Jeoung Park; Min-Hee Ryu; Chan-Hee Yoon; Hyun-Sook Chi; Seongsoo Jang; Sang-We Kim
The extended leukocyte differential count using the Cytodiff flow cytometric system reveals that higher CD16+ cytotoxic NK+T lymphocyte levels predict superior survival outcomes in patients with metastatic carcinoma.
Su Ssan Kim; Sang-We Kim; Woo Sung Kim; Jungwon Kwak; Jung-Shin Lee; Si Yeol Song; Seung Do Ahn; Jong Hoon Kim; Eun Kyung Choi
Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sang-We Kim (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Seung Jin Lee; Dae Hyuk Moon; Seung Jun Oh; Jin Sook Ryu; Jin-Hee Ahn; Eun Jung Kim; Seog Young Kim; Haeng Jung Lee; Sang-We Kim
A pilot study for the early assessment of the effects of BMS-754807 plus gefitinib in an H292 tumor model by [(18)F]fluorothymidine-positron emission tomography.
Investigational new drugs 2013;31(3):506-15.
2013: Borae G Park; Chan Jeoung Park; Min-Hee Ryu; Chan-Hee Yoon; Hyun-Sook Chi; Seongsoo Jang; Sang-We Kim
The extended leukocyte differential count using the Cytodiff flow cytometric system reveals that higher CD16+ cytotoxic NK+T lymphocyte levels predict superior survival outcomes in patients with metastatic carcinoma.
Cytometry. Part B, Clinical cytometry 2013;84(3):202-4.
2013: Su Ssan Kim; Sang-We Kim; Woo Sung Kim; Jungwon Kwak; Jung-Shin Lee; Si Yeol Song; Seung Do Ahn; Jong Hoon Kim; Eun Kyung Choi
Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumors.
Lung cancer (Amsterdam, Netherlands) 2013;79(2):161-6.
2013: Hee Jin Lee; Seung-Il Park; Young-Soo Park; Hyang Sook Seol; Young-Ah Suh; Dong Kwan Kim; Joo Young Kim; Sang-We Kim; Yong Hee Kim; Chang-Min Choi; Sung-Min Chun; Se Jin Jang
ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms.
Annals of surgical oncology 2013;20(1):200-8.
2012: Jong-Mu Sun; Hwan Jung Yun; Jin Seok Ahn; Myung-Ju Ahn; In Gyu Hwang; Sook Jung Jo; Bong-Seog Kim; Hoon-Kyo Kim; Sang-We Kim; Yeul Hong Kim; Dae Ho Lee; Jae Won Lee; Keehyun Lee; Ki Hyeong Lee; Young Joo Min; Keunchil Park; Hong Suk Song
Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01): an open-label, phase 3 trial.
Cancer 2012;118(24):6234-42.
2012: S J Park; Cheolwon Suh; H T Kim; K P Kim; Sang-We Kim; Dae Ho Lee; Jung-Shin Lee
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation.
Lung cancer (Amsterdam, Netherlands) 2012;77(3):556-60.
2012: Zhenfeng Zhang; Mohamed Abdel-Rahman; Maria Arcila; Valerie Au; Titus J Boggon; Chang-Min Choi; Yun Jung Choi; Carlota Costa; Balazs Halmos; Se Jin Jang; Sang-We Kim; Woo Sung Kim; Marc Ladanyi; Thomas LaFramboise; Dae Ho Lee; Jae Cheol Lee; Jung-Shin Lee; Alan D Levine; Luping Lin; Patrick C Ma; Vincent A Miller; Philicia Moonsamy; Victor Olivas; Young Soo Park; Jin Kyung Rho; Rafael Rosell; Charles Sawyers; Miquel Taron; Xiaoqi Wang; Trever G Bivona
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.
Nature genetics 2012;44(8):852-60.
2012: Eun Kyoung Kim; Jeong Eun Kim; Sang-We Kim; Dae Ho Lee; Ik-Soo Park; Byeong Seok Sohn; Cheolwon Suh
Angiosarcomas of the bilateral breast and heart: which one is the primary site?
The Korean journal of internal medicine 2012;27(2):224-8.
2012: Dae Ho Lee; Chang-Min Choi; Sang-We Kim; Cheolwon Suh; Jung-Shin Lee
Phase II study of pemetrexed plus oxaliplatin for platinum-resistant advanced or metastatic non-small cell lung cancer patients.
Medical oncology (Northwood, London, England) 2012;29(2):640-3.
2012: Vincent A Miller; Keunchil Park; Mehdi Shahidi; Wu-Chou Su; Yan Sun; Eng Huat Tan; Mengzhao Wang; Jacques Cadranel; Tsu-Yi Chao; Yuh-Min Chen; Xiuyu Julie Cong; Lucio Crino; Dae Seog Heo; Vera Hirsh; Sang-We Kim; Robert M Lorence; Caicun Zhou; James Chih-Hsin Yang
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial.
The lancet oncology 2012;13(5):528-38.
2012: Ji-Youn Han; Sook Jung Jo; Heung Tae Kim; Hyae Young Kim; Sang-We Kim; Dae Ho Lee; Jung-Shin Lee; Jae Won Lee; Keunchil Park; Cheolwon Suh; Sung Jin Yoon; Tak Yun; Jin Seok Ahn; Myung-Ju Ahn; Jong Hee Han; Jin Soo Lee
First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(10):1122-8.
2012: Min-Chul Cho; Chang-Min Choi; Sail Chun; Seongsoo Jang; Sejin Jang; Sollip Kim; Sang-We Kim; Woochang Lee; Chan Jeoung Park; Michael J Peyton; Hyun-Sook Chi; Won-Ki Min
Direct sequencing in cytological specimens as a useful strategy for detecting EGFR mutations in non-small cell lung cancer patients.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2012;50(3):565-72.
2012: Byeong S Sohn; Dok H Yoon; Eun K Kim; Hye O Kim; Sang-We Kim; Dae H Lee; Jin-Sook Ryu; Cheolwon Suh
The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study.
Onkologie 2012;35(7-8):432-8.
2011: Dal Yong Kim; Sang-We Kim; Dae Ho Lee; Sun-Joo Jang; Cheolwon Suh; Jung-Shin Lee
Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment.
Cancer research and treatment : official journal of Korean Cancer Association 2011;43(4):212-6.
2011: Dae Ro Choi; Sang-We Kim; Dae Ho Lee; Chang-Min Choi; Cheolwon Suh; Jung-Shin Lee
Erlotinib in first-line therapy for non-small cell lung cancer: a prospective phase II study.
Anticancer research 2011;31(10):3457-62.
2011: Manuel Salto-Tellez; Yuan-Kai Shi; Jin-Yuan Shih; Soo-Yong Tan; Sumitra Thongprasert; Ming-Sound Tsao; Joseph Siu-Kie Au; Gee-Chen Chang; Teh-Ying Chou; Jin-Hyoung Kang; Sang-We Kim; Jong-Seok Lee; Shun Lu; Ahmad Radzi; James Chih-Hsin Yang
Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: a combined clinical-molecular pathological approach.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(10):1663-9.
2011: Changhoon Yoo; Dae Ho Lee; Jeong Eun Kim; Jungmin Jo; Dok Hyun Yoon; Byeong Seok Sohn; Sang-We Kim; Jung-Shin Lee; Cheolwon Suh
Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP.
Annals of hematology 2011;90(7):797-802.
2011: Jeong-Eun Kim; Sang-We Kim; Dae Ho Lee; Eun Kyoung Kim; Cheolwon Suh; Jung-Shin Lee
False-positive hypermetabolic lesions on post-treatment PET-CT after influenza vaccination.
The Korean journal of internal medicine 2011;26(2):210-2.
2011: Gee-Chen Chang; Myung-Ju Ahn; Elaine Wright; Heung Tae Kim; Joo-Hang Kim; Jin Hyoung Kang; Sang-We Kim; Steven Sherman; Stefan Walzer
Comparative effectiveness of bevacizumab plus cisplatin-based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non-squamous non-small cell lung cancer patients applying real-life outcomes.
Asia-Pacific journal of clinical oncology 2011;7 Suppl 2():34-40.
2011: Myung-Ju Ahn; Chun-Ming Tsai; Te-Chun Hsia; Elaine Wright; John Wen-Cheng Chang; Heung Tae Kim; Joo-Hang Kim; Jin Hyoung Kang; Sang-We Kim; Eun-Jin Bae; Mijeong Kang; Johanna Lister; Stefan Walzer
Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan.
Asia-Pacific journal of clinical oncology 2011;7 Suppl 2():22-33.
2011: John Wen-Cheng Chang; Sumitra Thongprasert; Elaine Wright; Kenneth Tsang; Heung Tae Kim; Myung-Ju Ahn; Joo-Hang Kim; Jin Hyoung Kang; Sang-We Kim; Stefan Walzer
An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia.
Asia-Pacific journal of clinical oncology 2011;7 Suppl 2():13-21.
2011: J E Kim; Shin Kim; Sang-We Kim; Dae Ho Lee; Jung-Shin Lee; C Yoo; Cheolwon Suh
Optimal timing of G-CSF administration for effective autologous stem cell collection.
Bone marrow transplantation 2011;46(6):806-12.
2011: Jeong Eun Kim; Dae Ho Lee; Changhoon Yoo; Shin Kim; Sang-We Kim; Jung-Shin Lee; Chan Jeong Park; jooryung huh; Cheolwon Suh
BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: a single center comparative analysis of efficacy and toxicity.
Leukemia research 2011;35(2):183-7.
2011: Jae-Cheol Jo; Byung Woog Kang; Sun Jin Sym; Sung Sook Lee; Geundoo Jang; Shin Kim; Dae Ho Lee; Sang-We Kim; Jung-Shin Lee; Cheolwon Suh
Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma.
Investigational new drugs 2011;29(1):175-81.
2011: D H Yoon; Dae Ho Lee; D R Choi; B S Sohn; Shin Kim; Sang-We Kim; Jung-Shin Lee; S W Lee; jooryung huh; Cheolwon Suh
Feasibility of BU, CY and etoposide (BUCYE), and auto-SCT in patients with newly diagnosed primary CNS lymphoma: a single-center experience.
Bone marrow transplantation 2011;46(1):105-9.
2011: Dae Ho Lee; Sang-We Kim; Cheolwon Suh; Yun Hee Han; Jung-Shin Lee
Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets.
Cancer chemotherapy and pharmacology 2011;67(1):35-9.
2010: Kyu-Pyo Kim; Sang-We Kim
Chemotherapy for advanced non-small-cell lung cancer patients with poor performance.
Expert review of clinical pharmacology 2010;3(5):623-6.
2010: Changhoon Yoo; Shin Kim; Byeong Seok Sohn; Jeong-Eun Kim; Dok Hyun Yoon; jooryung huh; Dae Ho Lee; Sang-We Kim; Jung-Shin Lee; Cheolwon Suh
Modified number of extranodal involved sites as a prognosticator in R-CHOP-treated patients with disseminated diffuse large B-cell lymphoma.
The Korean journal of internal medicine 2010;25(3):301-8.
2010: Dok Hyun Yoon; Dae Ro Choi; Heui June Ahn; Shin Kim; Dae Ho Lee; Sang-We Kim; Bong-Hee Park; Sun Och Yoon; jooryung huh; Sang-Wook Lee; Cheolwon Suh
Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP.
European journal of haematology 2010;85(2):149-57.
2010: Byung Woog Kang; Won Seog Kim; Chul Kim; Geundoo Jang; Sung Sook Lee; Yoon Hee Choi; Dae Ho Lee; Sang-We Kim; Shin Kim; Jin-Sook Ryu; jooryung huh; Jung-Shin Lee; Cheolwon Suh
Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
Investigational new drugs 2010;28(4):516-22.
2010: Jeong Eun Kim; Changhoon Yoo; Dae Ho Lee; Sang-We Kim; Jung-Shin Lee; Cheolwon Suh
Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma.
Annals of hematology 2010;89(4):391-7.
2010: Dae Ho Lee; Keunchil Park; Joo-Hang Kim; Jong-Seok Lee; Sang Won Shin; Jin-Hyoung Kang; Myung-Ju Ahn; Jin Seok Ahn; Cheolwon Suh; Sang-We Kim
Randomized Phase III trial of gefitinib versus docetaxel in non-small cell lung cancer patients who have previously received platinum-based chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(4):1307-14.
2010: Dae Ho Lee; Sang-We Kim; Cheolwon Suh; Jung-Shin Lee; Jin Seok Ahn; Myung-Ju Ahn; Keunchil Park; Im Il Na; Jae Cheol Lee; Baek-Yeol Ryoo; Sung Hyun Yang
Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy-naive patients with extensive-disease small cell lung cancer.
Cancer 2010;116(1):132-6.
2009: S-S Park; Sang-We Kim; B-S Jung; Hyo-Suk Lee; Jong S Kim
Selective soft-tissue release for recurrent or residual deformity after conservative treatment of idiopathic clubfoot.
The Journal of bone and joint surgery. British volume 2009;91(11):1526-30.
2009: Da-tong Chu; Sang-We Kim; Hon-Ki Hsu; Gürsel Cok; Jaromir Roubec; Shekhar Patil; Danail Damyanov; Teena West; Belinda Hall; Sedat Altug
Patient attitudes towards chemotherapy and survival: a prospective observational study in advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2009;66(2):250-6.
2009: Seung Jin Choi; Seog Young Kim; Su Jin Kim; Jae Sung Lee; Seung Jin Lee; Soo Ah Park; Sang Ju Lee; Sung-Cheol Yun; Ki Chun Im; Seung Jun Oh; Sang-We Kim; Jae Seung Kim; Jin Sook Ryu; Dae Hyuk Moon
Reproducibility of the kinetic analysis of 3'-deoxy-3'-[(18)F]fluorothymidine positron emission tomography in mouse tumor models.
Nuclear medicine and biology 2009;36(7):711-9.
2009: Ji Eun Uhm; Park Byeong-bae; Myung-Ju Ahn; Jeeyun Lee; Jin Seok Ahn; Sang-We Kim; Heung Tae Kim; Jong Seog Lee; Jin Hyung Kang; Jae Yong Cho; Hong Suk Song; Se Hoon Park; Chang Hak Sohn; Sang Won Shin; Jin Hyuck Choi; Keunchil Park
Erlotinib monotherapy for stage IIIB/IV non-small cell lung cancer: a multicenter trial by the Korean Cancer Study Group.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(9):1136-43.
2009: Jeong-Eun Kim; Dae Ho Lee; Yunsuk Choi; Dok Hyun Yoon; Sang-We Kim; Cheolwon Suh; Jung-Shin Lee
Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis.
Lung cancer (Amsterdam, Netherlands) 2009;65(3):351-4.
2009: Jin Hyoung Kim; Ji Hoon Shin; Ho-Young Song; Joon-Young Ohm; Jae Moung Lee; Dae Ho Lee; Sang-We Kim
Palliative treatment of inoperable malignant tracheobronchial obstruction: temporary stenting combined with radiation therapy and/or chemotherapy.
AJR. American journal of roentgenology 2009;193(1):W38-42.
2009: Ock Bae Ko; Dae Ho Lee; Sang-We Kim; Jung-Shin Lee; Shin Kim; jooryung huh; Cheolwon Suh
Clinicopathologic characteristics of T-cell non-Hodgkin's lymphoma: a single institution experience.
The Korean journal of internal medicine 2009;24(2):128-34.
2009: Hee Jin Huh; Chan Jeoung Park; Sang-We Kim; Sang Hee Han; Seongsoo Jang; Hyun Sook Chi
Flow cytometric detection of platelet-associated immunoglobulin in patients with immune thrombocytopenic purpura and nonimmune thrombocytopenia.
Annals of clinical and laboratory science 2009;39(3):283-8.
2008: Jung-Wan Yoo; Dae Ho Lee; Ho June Song; Jin-Hee Ahn; Sang-We Kim; Cheolwon Suh; Jung-Shin Lee
Peritoneal dissemination from malignant fibrous histiocytoma of the buttock: unusual metastases from a rare tumor.
Gut and liver 2008;2(3):213-5.
2008: Hee-Jung Sohn; You-Jung Yang; Jin-Sook Ryu; Seung Jun Oh; Ki Chun Im; Dae Hyuk Moon; Dae Ho Lee; Cheolwon Suh; Jung-Shin Lee; Sang-We Kim
[18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7423-9.
2008: Yong Pil Chong; Shin Kim; Ok Bae Ko; Ja Eun Koo; Danbi Lee; Sang Hyoung Park; Soo Jung Park; Daeho Lee; Sang-We Kim; Cheolwon Suh
Poor outcomes for IgD multiple myeloma patients following high-dose melphalan and autologous stem cell transplantation: a single center experience.
Journal of Korean medical science 2008;23(5):819-24.
2008: Jae-Cheol Jo; Dae Ho Lee; Ho June Song; Sang-We Kim; Cheolwon Suh; Yoon-Koo Kang
Infarction and Perforation of the Small Intestine due to Tumor Emboli from Disseminated Rectal Cancer.
Gut and liver 2008;2(2):130-2.
2008: Myung-Ju Ahn; Park Byeong-bae; Jin Seok Ahn; Sang-We Kim; Heung Tae Kim; Jong Seog Lee; Jin Hyung Kang; Jae Yong Cho; Hong Suk Song; Se Hoon Park; Chang-Hak Sohn; Sang Won Shin; Jin Hyuck Choi; Ki Chang-Seok; Chan Keum Park; Alison J Holmes; Pasi A Janne; Keunchil Park
Are there any ethnic differences in molecular predictors of erlotinib efficacy in advanced non-small cell lung cancer?
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3860-6.
2007: Joon Oh Park; Sang-We Kim; Jin Seok Ahn; Cheolwon Suh; Jung Shin Lee; Joung Soon Jang; Eun Kyung Cho; Sung Hyun Yang; Jin-Hyuk Choi; Dae Seog Heo; Suk Young Park; Sang Won Shin; Myung-Ju Ahn; Jung-Shin Lee; Young Ho Yun; Jae-Won Lee; Keunchil Park
Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(33):5233-9.
2007: Dae Ho Lee; Sang-We Kim; Kyun-Seop Bae; Jeong-Sook Hong; Cheolwon Suh; Yoon-Koo Kang; Jung-Shin Lee
A phase I and pharmacologic study of belotecan in combination with cisplatin in patients with previously untreated extensive-stage disease small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6182-6.
2007: Min Kyoung Kim; Shin Kim; Sung Sook Lee; Sun Jin Sym; Dae Ho Lee; Sang-We Kim; Seongsoo Jang; Chan Jeoung Park; Hyun Sook Chi; jooryung huh; Cheolwon Suh
Rituximab-ESHAP as a mobilization regimen for relapsed or refractory B-cell lymphomas: a comparison with ESHAP.
Transfusion 2007;47(8):1447-54.
2007: Jae-Cheol Jo; Dae Ho Lee; Byung Wook Kang; Sung Sook Lee; Sun Jin Sym; Min Kyoung Kim; Jin-Hee Ahn; Jae-Lyun Lee; Sang-We Kim; Cheolwon Suh; Yoon-Koo Kang; Jung-Shin Lee
Both-sided intra-atrial intracardiac metastases as the initial presentation of testicular seminoma.
Japanese journal of clinical oncology 2007;37(6):463-8.
2007: Da-tong Chu; Sang-We Kim; Han-Pin Kuo; Rifat Ozacar; Frantisek Salajka; S Krishnamurthy; Danail Damyanov; Sedat Altug; William H H Reece; Li Wang
Patient attitudes towards chemotherapy as assessed by patient versus physician: a prospective observational study in advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2007;56(3):433-43.
2007: Min Kyoung Kim; Shin Kim; Geundoo Jang; Sung Sook Lee; Sun Jin Sym; Dae Ho Lee; Sang-We Kim; Seongsoo Jang; Chan Jeoung Park; Hyun Sook Chi; jooryung huh; Cheolwon Suh
A randomized comparison of peripheral blood hematopoietic progenitor cell level of 5/mm3 versus 50/mm3 as a surrogate marker to initiate efficient autologous blood stem cell collection.
Journal of clinical apheresis 2007;22(5):277-82.
2006: Sang Hyoung Park; Shin Kim; Ok Bae Ko; Ja Eun Koo; Danbi Lee; Yong Pil Jeong; jooryung huh; Sung-Bae Kim; Sang-We Kim; Jae-Lyun Lee; Cheolwon Suh
ESHAP salvage therapy for refractory and relapsed non-Hodgkin's lymphoma: a single center experience.
The Korean journal of internal medicine 2006;21(3):159-64.
2006: Harald Schulze; Manav Korpal; Jonathan Hurov; Sang-We Kim; Jinghang Zhang; Lewis C Cantley; Thomas Graf; Ramesh A Shivdasani
Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis.
Blood 2006;107(10):3868-75.
2006: Raymond P Abratt; Jung Sin Lee; Ji Youn Han; Chun-Ming Tsai; Michael Boyer; Tony Shu Kam Mok; Sang-We Kim; Jung Sin Lee; Alan J M Brnabic; William H H Reece; Manfred Lehnert
Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(2):135-40.
2005: Ock Bae Ko; Shin Kim; Hyeok Shim; Jung-Hun Lee; Jung-Min Ahn; Sang Min Yoon; Min-Hyok Jeon; Il No Do; So-young Lee; Yong Gil Kim; Sang-We Kim; Sung-Bae Kim; Sang-Hee Kim; Jung-Shin Lee; Wookun Kim; Chan-Jung Park; Hyun-sook Chi; Cheolwon Suh
Double autologous stem cell transplantation for multiple myeloma: a Korean single center study.
The Korean journal of internal medicine 2005;20(3):237-42.
2005: Hyun-Jung Sohn; Sang-Hee Kim; Gyeong-Won Lee; Shin Kim; Jin-Hee Ahn; Sung-Bae Kim; Sang-We Kim; Woo-Kun Kim; Cheolwon Suh
High-dose chemotherapy of cyclophosphamide, thiotepa and carboplatin (CTCb) followed by autologous stem-cell transplantation as a consolidation for breast cancer patients with 10 or more positive lymph nodes: a 5-year follow-up results.
Cancer research and treatment : official journal of Korean Cancer Association 2005;37(3):137-42.
2005: Young Seok Kim; Sang Min Yoon; Eun Kyung Choi; Byong Yong Yi; Jong Hoon Kim; Seung Do Ahn; Sang-Wook Lee; Seong Soo Shin; Jung-Shin Lee; Cheolwon Suh; Sang-We Kim; Dong Soon Kim; Woo Sung Kim; Heon Joo Park; Chan Il Park
Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2005;62(1):76-81.
2005: Hyun-Jung Sohn; Sang-Hee Kim; Gyeong-Won Lee; Shin Kim; Hye Jin Kang; Jin-Hee Ahn; Sung-Bae Kim; Sang-We Kim; Woo-Kun Kim; Cheolwon Suh
High-dose chemotherapy of cyclophosphamide, thiotepa, and carboplatin (CTCb) followed by autologous stem-cell transplantation for metastatic breast cancer patients: a 6-year follow-up result.
Cancer research and treatment : official journal of Korean Cancer Association 2005;37(1):24-30.
2004: Cheolwon Suh; Shin Kim; Sang-Hee Kim; Eun-Kyung Kim; Jae-Lyun Lee; Kyoung Un Park; Jung Sun Park; Jungsin Lee; Michael W Kim; Hyun Sook Chi; Chan Jeoung Park; Sang-We Kim
Initiation of peripheral blood progenitor cell harvest based on peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE9000.
Transfusion 2004;44(12):1762-8.
2004: Jin-Hee Ahn; Sang-We Kim; Seung-Mo Hong; Cheolwon Suh; Woo-Kun Kim; In-Chul Lee; Jung-Shin Lee
Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma.
Journal of Korean medical science 2004;19(4):529-35.
2004: Mi-Woo Lee; Chul-Won Seo; Sang-We Kim; Hwa-Jeong Yang; Hae-Woong Lee; Jee-Ho Choi; Kee-Chan Moon; Jai-Kyoung Koh
Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor.
Acta dermato-venereologica 2004;84(1):23-6.
2004: Jae-Lyun Lee; Yoon-Koo Kang; Tae Won Kim; Heung Moon Chang; Gyeong-Won Lee; Min-Hee Ryu; Eunkyoung Kim; Seok-Joong Oh; Je-Hwan Lee; Sung-Bae Kim; Sang-We Kim; Cheolwon Suh; Kyoo-Hyung Lee; Jung-Shin Lee; Woo-Kun Kim; Sang-Hee Kim
Leptomeningeal carcinomatosis in gastric cancer.
Journal of neuro-oncology 2004;66(1-2):167-74.
2003: Gyeong-Won Lee; Min-Hee Ryu; Jae-Lyun Lee; Sukjoong Oh; Eunkyoung Kim; Jae-Hwan Lee; Seung-Bae Kim; Sang-We Kim; Cheolwon Suh; Kyoo-Hyung Lee; Woo-Kun Kim; Jung-Shin Lee; Yoon-Koo Kang
The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy.
Journal of Korean medical science 2003;18(6):849-54.
2003: Ji Hoon Shin; Sang-We Kim; Tae Sun Shim; Gyoo-Sik Jung; Tae-Hyung Kim; Gi-Young Ko; Ho-Young Song
Malignant tracheobronchial strictures: palliation with covered retrievable expandable nitinol stent.
Journal of vascular and interventional radiology : JVIR 2003;14(12):1525-34.
2003: Sang-We Kim; Hyo Jung Kim; Sung Bae Kim; Cheolwon Suh; Jung Shik Shin; Jung Sun Park; Gyungyub Gong; Jung-Shin Lee; Sang-Hee Kim
Murine bone marrow stromal cells: implications for their use in gene modified cell therapy.
Leukemia & lymphoma 2003;44(11):1973-8.
2003: Sang-We Kim; Cheolwon Suh; Sang Do Lee; Woo Sung Kim; Dong Soon Kim; Won Dong Kim; Jung Sin Lee
Weekly low dose paclitaxel and cisplatin as first-line chemotherapy for advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;41(2):221-6.
2003: Sang-wook Lee; Eun Kyung Choi; Jung-Shin Lee; Sang Do Lee; Cheolwon Suh; Sang-We Kim; Woo Sung Kim; Seung Do Ahn; Byong Yong Yi; Jong Hoon Kim; Young Ju Noh; Su Ssan Kim; Younsuck Koh; Dong Soon Kim; Won Dong Kim
Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2003;56(4):996-1004.
2002: Geun Doo Jang; Sang-We Kim; Cheol Won Suh; Eun-Kyoung Kim; Hyeseung Bahng; Young-Hoon Jeong; Il Gwon Park; Woo-Kun Kim; Sang-Hee Kim; Eul-Ju Suh; Chan Jeoung Park; Hyun-Sook Ji; Jung-Shin Lee
A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
Journal of Korean medical science 2002;17(4):555-9.
2002: Sang-wook Lee; Eun Kyung Choi; Weon Kuu Chung; Kyung Hwan Shin; Seung Do Ahn; Jong Hoon Kim; Sang-We Kim; Cheolwon Suh; Jung-Shin Lee; Woo Sung Kim; Dong Soon Kim; Dong Kwan Kim; Seung-Il Park; Kwang-Hyun Sohn
Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).
Lung cancer (Amsterdam, Netherlands) 2002;37(1):65-71.
2000: P Lecine; Joseph E Italiano; Sang-We Kim; Jean-Luc Villeval; Ramesh A Shivdasani
Hematopoietic-specific beta 1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2.
Blood 2000;96(4):1366-73.
2000: Young Joo Min; Sang-We Kim; Cheolwon Suh; J Park; Ho Jeong Kim; Jong Gwang Kim; Tae Won Kim; Je-Hwan Lee; Soon Bae Kim; Kyoo-Hyung Lee; Jin Seong Lee; Woo-Kun Kim; Sang-Hee Kim
The possible cost effectiveness of peripheral blood stem cell mobilization with cyclophosphamide and the late addition of G-CSF.
Journal of Korean medical science 2000;15(1):49-52.
1999: Sang-Hee Kim; Cheolwon Suh; Seong-Jun Choi; Jong Gwang Kim; Je-Hwan Lee; Soon Bae Kim; Sang-We Kim; Kyoo-Hyung Lee; Jin Seong Lee; Woo-Kun Kim; S H Kim; Eul-Ju Seo; Hyun Sook Chi
Myelodysplastic syndrome that progressed to acute myelomonocytic leukemia with eosinophilia showing peculiar chromosomal abnormality: a case report.
Journal of Korean medical science 1999;14(4):448-50.
1998: Tae Won Kim; Woo-Kun Kim; Je-Hwan Lee; Soon Bae Kim; Sang-We Kim; Cheolwon Suh; Kyoo-Hyung Lee; Jin Seong Lee; Eul-Ju Seo; Hyun Sook Chi; Sang-Hee Kim
Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
Journal of Korean medical science 1998;13(6):587-90.
1998: Hyeseung Bahng; Je-Hwan Lee; Cheolwon Suh; Jin-Hee Ahn; Soon Bae Kim; Sang-We Kim; Kyoo-Hyung Lee; Jin Seong Lee; Woo-Kun Kim; Chan Jeoung Park; Hyun Sook Chi; Sang-Hee Kim
Severe aplastic anemia induced by ticlopidine: report of two cases.
Journal of Korean medical science 1998;13(5):541-4.
1996: Kyoo-Hyung Lee; Jin Seong Lee; Cheolwon Suh; Sang-We Kim; Soon Bae Kim; Je-Hwan Lee; D Y Zang; D S Lee; Hyun Sook Chi; M S Lee; Woo-Kun Kim; Sang-Hee Kim
Prognostic factors of acute myelocytic leukemia: an analysis of 132 patients in a single institution.
Journal of Korean medical science 1996;11(3):222-32.
1996: Je-Hwan Lee; Kyoo-Hyung Lee; J S Choi; D Y Zang; Soon Bae Kim; Sang-We Kim; Cheolwon Suh; Jin Seong Lee; Woo-Kun Kim; Yung Sang Lee; Sang-Hee Kim
Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
Journal of Korean medical science 1996;11(2):118-26.
1995: Kyoo-Hyung Lee; Jin Seong Lee; Cheolwon Suh; Sang-We Kim; Soon Bae Kim; Je-Hwan Lee; M S Lee; M Y Park; H S Sun; Sang-Hee Kim
Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases.
Cancer 1995;75(12):2794-801.
1995: Soon Bae Kim; Sang-Hee Kim; Kyoo-Hyung Lee; J W Lee; Sang-We Kim; Cheolwon Suh; Jin Seong Lee; Ho-Young Song; H S Chang; E K Choi
Preoperative chemoradiotherapy for locoregional esophageal cancer: preliminary report.
Journal of Korean medical science 1995;10(2):111-20.
1994: Kyoo-Hyung Lee; D H Kim; Jin Seong Lee; Cheolwon Suh; Sang-We Kim; Soon Bae Kim; Je-Hwan Lee; B S Doh; Hyun Sook Chi; M S Lee
Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
Journal of Korean medical science 1994;9(6):437-43.
1994: Cheol Whan Lee; Cheolwon Suh; Jin Seong Lee; Kyoo-Hyung Lee; G Y Cho; Sang-We Kim; Sang-Hee Kim
Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis.
Journal of Korean medical science 1994;9(5):369-75.
1993: Kyoo-Hyung Lee; Jin Seong Lee; Cheolwon Suh; Myung-Ju Ahn; Sang-We Kim; B S Doh; Y I Min; B S Kim; K C Park; I C Lee
DNA flow cytometry of stomach cancer. Prospective correlation with clinicopathologic findings.
Cancer 1993;72(6):1819-26.
1993: Sang-We Kim; Kyoo-Hyung Lee; Jin Seong Lee; Cheolwon Suh; Myung-Ju Ahn; S W Kim; Hyun Sook Chi; Sang-Hee Kim
A complete remission can be achieved despite persistence of abnormal bone marrow promyelocytes in acute promyelocytic leukemia--experience in 2 patients.
Journal of Korean medical science 1993;8(4):246-50.